In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was approved. The drug, known as ipilimumab or Yervoy, stood apart from standard cancer treatments. It worked by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback